NanoViricides
NNVC
#10075
Rank
A$39.44 M
Marketcap
A$1.83
Share price
-2.42%
Change (1 day)
-24.32%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: A$39.44 Million

As of December 2025 NanoViricides has a market cap of A$39.44 Million. This makes NanoViricides the world's 10075th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025A$39.44 M14.02%
2024A$34.59 M96.75%
2023A$17.58 M-7.14%
2022A$18.93 M-67.98%
2021A$59.13 M48.56%
2020A$39.8 M186.87%
2019A$13.87 M-29.68%
2018A$19.73 M-72.36%
2017A$71.39 M-17.36%
2016A$86.39 M-7.75%
2015A$93.66 M-50.18%
2014A$0.18 B-30.19%
2013A$0.26 B274.01%
2012A$72 M-18.96%
2011A$88.84 M-55.77%
2010A$0.20 B60.92%
2009A$0.12 B-11.4%
2008A$0.14 B165.05%
2007A$53.15 M

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of NanoViricides was reported to be:

A$52.94 Million
by Nasdaq info icon info icon
A$39.44 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
A$2.32 B 5,786.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.64 B 4,059.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$227.82 B 577,423.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$164.10 B 415,899.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$380.17 B 963,589.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$147.26 B 373,191.35%๐Ÿ‡ฌ๐Ÿ‡ง UK